Study to assess the safety, tolerability and pharmacokinetics and pharmacodynamics of AZD0284 in healthy subjects

Trial Identifier:	D7800C00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT02976831
Start Date:	December 2016
Primary Completion Date:	May 2017
Study Completion Date:	May 2017
Condition:	Psoriasis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.